Gilead Sciences Inc Assembly Biosciences, Inc. (ASMB) insider trading activity

Gilead Sciences Inc is > 10% Shareholder of ASSEMBLY BIOSCIENCES, INC.. Currently has a direct ownership of 1.27 Million shares of ASMB, which is worth approximately $18.8 Million. The most recent transaction as insider was on Jun 17, 2024, when has been sold 179,500 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.27M

0% 3M change

n/a 12M change

Total Value Held $18.8 Million

GILEAD SCIENCES INC Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Jun 17 2024	BUY Open market or private purchase	-	179,500 Added 12.39%	1,268,972 Common Stock

Also insider at

RCUS

Arcus Biosciences, Inc. Healthcare

> 10% Shareholder

ALVR

Allovir, Inc. Healthcare

> 10% Shareholder

KYTX

Kyverna Therapeutics, Inc.

> 10% Shareholder

XLO

Xilio Therapeutics, Inc. Healthcare

> 10% Shareholder

GSI